Evidence map›Paper›PMID 32753691›Full record

ArticleScientific reports2020

Publisher Correction: Pyroglutamic acidosis as a cause for high anion gap metabolic acidosis: a prospective study.

Shir Raibman Spector, Haim Mayan, Ronen Loebstein, Noa Markovits, Eldar Priel, Eias Massalha, Yuval Shafir, Itai Gueta

Abstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Shir Raibman Spector *Department of Medicine E, Sheba Medical Center, Tel Hashomer, Israel.
Haim Mayan *Department of Medicine E, Sheba Medical Center, Tel Hashomer, Israel.
Ronen LoebsteinThe Institute for Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel.
Noa MarkovitsThe Institute for Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel.
Eldar PrielDepartment of Medicine E, Sheba Medical Center, Tel Hashomer, Israel.
Eias MassalhaDepartment of Medicine E, Sheba Medical Center, Tel Hashomer, Israel.
Yuval ShafirDepartment of Medicine E, Sheba Medical Center, Tel Hashomer, Israel.
Itai GuetaThe Institute for Clinical Pharmacology and Toxicology, Sheba Medical Center, Tel Hashomer, Israel. Itai.Gueta@sheba.gov.il.ORCID http://orcid.org/0000-0001-6631-8415

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32753691
PMCPMC7403596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.